Characterization of Local Vascular Effects of LNMMA

This study has been completed.
Information provided by:
Technische Universität Dresden Identifier:
First received: September 9, 2005
Last updated: November 1, 2005
Last verified: September 2005

Characterization of an unexpected venodilative effect of higher L-NMMA-doses in dorsal human hand veins.

Condition Intervention
Healthy Subjects
Drug: L-NMMA(drug)

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by Technische Universität Dresden:

Study Start Date: October 2003
Estimated Study Completion Date: September 2005

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • healthy subjects

Exclusion Criteria:

  • any relevant disease
  Contacts and Locations
Please refer to this study by its identifier: NCT00180063

Institute of Clinical Pharmacology, Medical Faculty, University of Technology
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Study Chair: Wilhelm Kirch, MD Institute of Clinical Pharmacology
  More Information

No publications provided by Technische Universität Dresden

Additional publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00180063     History of Changes
Other Study ID Numbers: IKPD 01-02 Amend LNMMA
Study First Received: September 9, 2005
Last Updated: November 1, 2005
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions processed this record on April 16, 2014